Avantor, Inc. (NYSE: AVTR) Stock Competitors & Peer Comparison
See AVTR's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AVTR and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVTR | $15.47 | +2.18% | 10.5B | 18.19 | $0.85 | N/A |
| ISRG | $452.80 | -3.36% | 160B | 47.07 | $9.62 | N/A |
| BDX | $211.88 | -0.78% | 57.7B | 16.30 | $13.00 | +1.88% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +1.88% |
| MDLN | $39.64 | -0.30% | 34.8B | 29.06 | $1.36 | N/A |
| RMD | $235.30 | -1.68% | 33.1B | 20.40 | $11.53 | +1.06% |
| WST | $399.81 | +1.87% | 27.9B | 43.48 | $9.20 | +0.22% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $90.38 | +3.67% | 15.4B | 12.73 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +1.88% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
AVTR vs ISRG Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ISRG has a market cap of 160B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ISRG trades at $452.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ISRG's P/E ratio is 47.07. In terms of profitability, AVTR's ROE is +0.06%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, AVTR is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDX)
AVTR vs BDX Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, BDX has a market cap of 57.7B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while BDX trades at $211.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas BDX's P/E ratio is 16.30. In terms of profitability, AVTR's ROE is +0.06%, compared to BDX's ROE of +0.04%. Regarding short-term risk, AVTR is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
AVTR vs BDXA Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas BDXA's P/E ratio is 45.70. In terms of profitability, AVTR's ROE is +0.06%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, AVTR is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
AVTR vs MDLN Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, MDLN has a market cap of 34.8B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while MDLN trades at $39.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas MDLN's P/E ratio is 29.06. In terms of profitability, AVTR's ROE is +0.06%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, AVTR is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check MDLN's competition here
ResMed Inc. (NYSE: RMD)
AVTR vs RMD Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, RMD has a market cap of 33.1B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while RMD trades at $235.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas RMD's P/E ratio is 20.40. In terms of profitability, AVTR's ROE is +0.06%, compared to RMD's ROE of +0.25%. Regarding short-term risk, AVTR is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check RMD's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
AVTR vs WST Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, WST has a market cap of 27.9B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while WST trades at $399.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas WST's P/E ratio is 43.48. In terms of profitability, AVTR's ROE is +0.06%, compared to WST's ROE of +0.21%. Regarding short-term risk, AVTR is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
AVTR vs HOLX Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas HOLX's P/E ratio is 31.54. In terms of profitability, AVTR's ROE is +0.06%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, AVTR is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
AVTR vs SOLV Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, SOLV has a market cap of 15.4B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while SOLV trades at $90.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas SOLV's P/E ratio is 12.73. In terms of profitability, AVTR's ROE is +0.06%, compared to SOLV's ROE of +0.03%. Regarding short-term risk, AVTR is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
AVTR vs BDXB Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas BDXB's P/E ratio is 7.60. In terms of profitability, AVTR's ROE is +0.06%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, AVTR is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
AVTR vs BAX Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, BAX has a market cap of 13.3B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while BAX trades at $25.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas BAX's P/E ratio is 12.39. In terms of profitability, AVTR's ROE is +0.06%, compared to BAX's ROE of -0.12%. Regarding short-term risk, AVTR is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check BAX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
AVTR vs COO Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, COO has a market cap of 11.9B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while COO trades at $62.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas COO's P/E ratio is 13.67. In terms of profitability, AVTR's ROE is +0.06%, compared to COO's ROE of +0.07%. Regarding short-term risk, AVTR is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
AVTR vs RGEN Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, RGEN has a market cap of 11.1B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while RGEN trades at $173.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas RGEN's P/E ratio is 96.38. In terms of profitability, AVTR's ROE is +0.06%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, AVTR is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
AVTR vs ATR Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ATR has a market cap of 9B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ATR trades at $142.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ATR's P/E ratio is 24.92. In terms of profitability, AVTR's ROE is +0.06%, compared to ATR's ROE of +0.10%. Regarding short-term risk, AVTR is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
AVTR vs BLCO Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, BLCO has a market cap of 7.1B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while BLCO trades at $19.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas BLCO's P/E ratio is 30.72. In terms of profitability, AVTR's ROE is +0.06%, compared to BLCO's ROE of -0.02%. Regarding short-term risk, AVTR is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
AVTR vs TFX Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, TFX has a market cap of 6.4B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while TFX trades at $150.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas TFX's P/E ratio is 17.22. In terms of profitability, AVTR's ROE is +0.06%, compared to TFX's ROE of +0.10%. Regarding short-term risk, AVTR is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
AVTR vs MMSI Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, MMSI has a market cap of 5.2B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while MMSI trades at $87.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas MMSI's P/E ratio is 22.30. In terms of profitability, AVTR's ROE is +0.06%, compared to MMSI's ROE of +0.10%. Regarding short-term risk, AVTR is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
AVTR vs ICUI Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ICUI has a market cap of 4.3B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ICUI trades at $172.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ICUI's P/E ratio is 21.53. In terms of profitability, AVTR's ROE is +0.06%, compared to ICUI's ROE of +0.03%. Regarding short-term risk, AVTR is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
AVTR vs NVST Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, NVST has a market cap of 4B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while NVST trades at $25.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas NVST's P/E ratio is 17.13. In terms of profitability, AVTR's ROE is +0.06%, compared to NVST's ROE of +0.21%. Regarding short-term risk, AVTR is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
AVTR vs PLSE Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while PLSE trades at $53.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas PLSE's P/E ratio is -45.08. In terms of profitability, AVTR's ROE is +0.06%, compared to PLSE's ROE of -0.78%. Regarding short-term risk, AVTR is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check PLSE's competition here
Stevanato Group S.p.A. (NYSE: STVN)
AVTR vs STVN Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, STVN has a market cap of 3.7B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while STVN trades at $13.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas STVN's P/E ratio is 20.50. In terms of profitability, AVTR's ROE is +0.06%, compared to STVN's ROE of +0.09%. Regarding short-term risk, AVTR is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check STVN's competition here
AtriCure, Inc. (NASDAQ: ATRC)
AVTR vs ATRC Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ATRC has a market cap of 3B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ATRC trades at $58.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ATRC's P/E ratio is 1817.08. In terms of profitability, AVTR's ROE is +0.06%, compared to ATRC's ROE of +0.03%. Regarding short-term risk, AVTR is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check ATRC's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
AVTR vs BLFS Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while BLFS trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas BLFS's P/E ratio is 37.49. In terms of profitability, AVTR's ROE is +0.06%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, AVTR is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check BLFS's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
AVTR vs XRAY Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while XRAY trades at $9.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas XRAY's P/E ratio is 6.62. In terms of profitability, AVTR's ROE is +0.06%, compared to XRAY's ROE of -0.09%. Regarding short-term risk, AVTR is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
AVTR vs LMAT Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while LMAT trades at $80.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas LMAT's P/E ratio is 29.76. In terms of profitability, AVTR's ROE is +0.06%, compared to LMAT's ROE of +0.15%. Regarding short-term risk, AVTR is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check LMAT's competition here
Azenta, Inc. (NASDAQ: AZTA)
AVTR vs AZTA Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, AZTA has a market cap of 1.7B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while AZTA trades at $39.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas AZTA's P/E ratio is 93.33. In terms of profitability, AVTR's ROE is +0.06%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, AVTR is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
AVTR vs KMTS Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, KMTS has a market cap of 1.7B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while KMTS trades at $28.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas KMTS's P/E ratio is -10.86. In terms of profitability, AVTR's ROE is +0.06%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, AVTR is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
AVTR vs STAA Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, STAA has a market cap of 1.3B. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while STAA trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas STAA's P/E ratio is 44.23. In terms of profitability, AVTR's ROE is +0.06%, compared to STAA's ROE of +0.00%. Regarding short-term risk, AVTR is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
AVTR vs ATRI Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ATRI's P/E ratio is 64.50. In terms of profitability, AVTR's ROE is +0.06%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, AVTR is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ATRI's competition here
MiniMed Group, Inc. (NASDAQ: MMEDV)
AVTR vs MMEDV Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, MMEDV has a market cap of 495.6M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while MMEDV trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas MMEDV's P/E ratio is N/A. In terms of profitability, AVTR's ROE is +0.06%, compared to MMEDV's ROE of N/A. Regarding short-term risk, AVTR is more volatile compared to MMEDV. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check MMEDV's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
AVTR vs ANGO Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ANGO has a market cap of 493.1M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ANGO trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ANGO's P/E ratio is -30.06. In terms of profitability, AVTR's ROE is +0.06%, compared to ANGO's ROE of -0.19%. Regarding short-term risk, AVTR is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ANGO's competition here
Embecta Corp. (NASDAQ: EMBC)
AVTR vs EMBC Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, EMBC has a market cap of 350M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while EMBC trades at $6.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas EMBC's P/E ratio is 2.38. In terms of profitability, AVTR's ROE is +0.06%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, AVTR is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
AVTR vs SMTI Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, SMTI has a market cap of 289.9M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while SMTI trades at $31.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas SMTI's P/E ratio is -525.83. In terms of profitability, AVTR's ROE is +0.06%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, AVTR is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
AVTR vs OSUR Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, OSUR has a market cap of 237.9M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while OSUR trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas OSUR's P/E ratio is -5.00. In terms of profitability, AVTR's ROE is +0.06%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, AVTR is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
AVTR vs UTMD Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, UTMD has a market cap of 230.4M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while UTMD trades at $72.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas UTMD's P/E ratio is 21.48. In terms of profitability, AVTR's ROE is +0.06%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, AVTR is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
AVTR vs PDEX Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, PDEX has a market cap of 201M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while PDEX trades at $63.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas PDEX's P/E ratio is 17.21. In terms of profitability, AVTR's ROE is +0.06%, compared to PDEX's ROE of +0.26%. Regarding short-term risk, AVTR is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check PDEX's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
AVTR vs NNNN Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, NNNN has a market cap of 169M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while NNNN trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas NNNN's P/E ratio is 25.67. In terms of profitability, AVTR's ROE is +0.06%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, AVTR is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NNNN's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
AVTR vs KRMD Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, KRMD has a market cap of 141.7M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while KRMD trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas KRMD's P/E ratio is -77.12. In terms of profitability, AVTR's ROE is +0.06%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, AVTR is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
AVTR vs STXS Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, STXS has a market cap of 111.2M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while STXS trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas STXS's P/E ratio is -6.53. In terms of profitability, AVTR's ROE is +0.06%, compared to STXS's ROE of -1.33%. Regarding short-term risk, AVTR is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
AVTR vs AKYA Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas AKYA's P/E ratio is -1.34. In terms of profitability, AVTR's ROE is +0.06%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, AVTR is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check AKYA's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
AVTR vs POCI Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, POCI has a market cap of 53.8M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while POCI trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas POCI's P/E ratio is -10.66. In terms of profitability, AVTR's ROE is +0.06%, compared to POCI's ROE of -0.24%. Regarding short-term risk, AVTR is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check POCI's competition here
SkyAI, Inc. (NASDAQ: STSS)
AVTR vs STSS Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas STSS's P/E ratio is -0.02. In terms of profitability, AVTR's ROE is +0.06%, compared to STSS's ROE of -1.54%. Regarding short-term risk, AVTR is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
AVTR vs OMIC Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas OMIC's P/E ratio is -0.58. In terms of profitability, AVTR's ROE is +0.06%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, AVTR is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
AVTR vs IGAP Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas IGAP's P/E ratio is -10.52. In terms of profitability, AVTR's ROE is +0.06%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, AVTR is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check IGAP's competition here
Daxor Corporation (NASDAQ: DXR)
AVTR vs DXR Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, DXR has a market cap of 49.4M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while DXR trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas DXR's P/E ratio is 6.88. In terms of profitability, AVTR's ROE is +0.06%, compared to DXR's ROE of +0.13%. Regarding short-term risk, AVTR is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check DXR's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
AVTR vs HBIO Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, HBIO has a market cap of 38.2M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while HBIO trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas HBIO's P/E ratio is -23.31. In terms of profitability, AVTR's ROE is +0.06%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, AVTR is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check HBIO's competition here
Nephros, Inc. (NASDAQ: NEPH)
AVTR vs NEPH Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, NEPH has a market cap of 30.6M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while NEPH trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas NEPH's P/E ratio is 46.92. In terms of profitability, AVTR's ROE is +0.06%, compared to NEPH's ROE of +0.17%. Regarding short-term risk, AVTR is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NEPH's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
AVTR vs SDC Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas SDC's P/E ratio is -0.03. In terms of profitability, AVTR's ROE is +0.06%, compared to SDC's ROE of -1.96%. Regarding short-term risk, AVTR is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check SDC's competition here
Milestone Scientific Inc. (AMEX: MLSS)
AVTR vs MLSS Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, MLSS has a market cap of 27.5M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while MLSS trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas MLSS's P/E ratio is -6.07. In terms of profitability, AVTR's ROE is +0.06%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, AVTR is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check MLSS's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
AVTR vs ZJYL Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ZJYL has a market cap of 26.1M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ZJYL trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ZJYL's P/E ratio is 22.78. In terms of profitability, AVTR's ROE is +0.06%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, AVTR is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check ZJYL's competition here
Invacare Corporation (NYSE: IVC)
AVTR vs IVC Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas IVC's P/E ratio is -0.79. In terms of profitability, AVTR's ROE is +0.06%, compared to IVC's ROE of -0.46%. Regarding short-term risk, AVTR is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
AVTR vs RVP Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, RVP has a market cap of 16.9M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while RVP trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas RVP's P/E ratio is -4.69. In terms of profitability, AVTR's ROE is +0.06%, compared to RVP's ROE of -0.05%. Regarding short-term risk, AVTR is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
AVTR vs BNGO Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, BNGO has a market cap of 13.5M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while BNGO trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas BNGO's P/E ratio is -0.38. In terms of profitability, AVTR's ROE is +0.06%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, AVTR is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check BNGO's competition here
Femasys Inc. (NASDAQ: FEMY)
AVTR vs FEMY Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, FEMY has a market cap of 11.6M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while FEMY trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas FEMY's P/E ratio is -0.31. In terms of profitability, AVTR's ROE is +0.06%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, AVTR is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
AVTR vs RGNT Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, RGNT has a market cap of 8.1M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while RGNT trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas RGNT's P/E ratio is -0.47. In terms of profitability, AVTR's ROE is +0.06%, compared to RGNT's ROE of N/A. Regarding short-term risk, AVTR is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check RGNT's competition here
Lucyd, Inc (NASDAQ: LUCY)
AVTR vs LUCY Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, LUCY has a market cap of 7.2M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while LUCY trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas LUCY's P/E ratio is -0.64. In terms of profitability, AVTR's ROE is +0.06%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, AVTR is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
AVTR vs NSTG Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas NSTG's P/E ratio is -0.03. In terms of profitability, AVTR's ROE is +0.06%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, AVTR is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NSTG's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
AVTR vs CUPR Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, CUPR has a market cap of 4.8M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while CUPR trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas CUPR's P/E ratio is -1.31. In terms of profitability, AVTR's ROE is +0.06%, compared to CUPR's ROE of -0.85%. Regarding short-term risk, AVTR is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check CUPR's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
AVTR vs POAI Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas POAI's P/E ratio is -0.38. In terms of profitability, AVTR's ROE is +0.06%, compared to POAI's ROE of -21.19%. Regarding short-term risk, AVTR is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
AVTR vs MHUA Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas MHUA's P/E ratio is 0.25. In terms of profitability, AVTR's ROE is +0.06%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, AVTR is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
AVTR vs GMVD Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas GMVD's P/E ratio is -0.01. In terms of profitability, AVTR's ROE is +0.06%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, AVTR is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
AVTR vs GMVDW Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas GMVDW's P/E ratio is N/A. In terms of profitability, AVTR's ROE is +0.06%, compared to GMVDW's ROE of +3.68%. Regarding short-term risk, AVTR is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check GMVDW's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
AVTR vs NXGL Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, NXGL has a market cap of 1.7M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while NXGL trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas NXGL's P/E ratio is -5.01. In terms of profitability, AVTR's ROE is +0.06%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, AVTR is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NXGL's competition here
Avinger, Inc. (NASDAQ: AVGR)
AVTR vs AVGR Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas AVGR's P/E ratio is -0.05. In terms of profitability, AVTR's ROE is +0.06%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, AVTR is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
AVTR vs NXGLW Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, NXGLW has a market cap of 496.3K. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas NXGLW's P/E ratio is -0.01. In terms of profitability, AVTR's ROE is +0.06%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, AVTR is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
AVTR vs LUCYW Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas LUCYW's P/E ratio is N/A. In terms of profitability, AVTR's ROE is +0.06%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, AVTR is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for AVTR.Check LUCYW's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
AVTR vs HRC Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, HRC has a market cap of 0. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas HRC's P/E ratio is 41.92. In terms of profitability, AVTR's ROE is +0.06%, compared to HRC's ROE of +0.14%. Regarding short-term risk, AVTR is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check HRC's competition here
Analogic Corporation (NASDAQ: ALOG)
AVTR vs ALOG Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ALOG's P/E ratio is 40.93. In terms of profitability, AVTR's ROE is +0.06%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, AVTR is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
AVTR vs ATRS Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas ATRS's P/E ratio is 14.95. In terms of profitability, AVTR's ROE is +0.06%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, AVTR is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check ATRS's competition here
IntriCon Corporation (NASDAQ: IIN)
AVTR vs IIN Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, IIN has a market cap of 0. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas IIN's P/E ratio is 226.45. In terms of profitability, AVTR's ROE is +0.06%, compared to IIN's ROE of -0.00%. Regarding short-term risk, AVTR is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check IIN's competition here
Apria, Inc. (NASDAQ: APR)
AVTR vs APR Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, APR has a market cap of 0. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas APR's P/E ratio is 22.59. In terms of profitability, AVTR's ROE is +0.06%, compared to APR's ROE of +9.81%. Regarding short-term risk, AVTR is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check APR's competition here
Invuity, Inc. (NASDAQ: IVTY)
AVTR vs IVTY Comparison November 2026
Avantor, Inc. (NYSE: AVTR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVTR stands at 10.5B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, AVTR is priced at $15.47 on the NYSE, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVTR currently has a P/E ratio of 18.19, whereas IVTY's P/E ratio is -3.80. In terms of profitability, AVTR's ROE is +0.06%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, AVTR is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for AVTR.Check IVTY's competition here